SFU Library Licensed Material

Access to the content in this collection is restricted to current SFU faculty, students, and staff.

This collection contains various types of content licensed by the SFU Library on behalf of the University. 

Copyright and Terms of use

This work is protected by copyright in Canada unless its copyright has expired. The user is responsible for doing their own assessment. 

You may use this work as permitted by applicable licenses, fair dealing and other exceptions under copyright legislation in your jurisdiction. For guidance on seeking further permissions, contact the source/owner of the material.

Search within Collection

Displaying 31 - 45 of 710

Best Practices in Financial Services Technology,Datamonitor report

BI00029-002-Thumbnail Image.png
Date: 2006-09-20
Name(s): Furness, Victoria
Description: The financial services sector is an industry that vendors recognise as offering lucrative returns two of the three largest software vendors have heavily targeted this area in recent years but it is also one of the hardest for outsiders to enter.

Biomarkers in Late Stage Clinical Trials,Datamonitor report

BI00027-034-Thumbnail Image.png
Date: 2010-04-01
Name(s): Merchant, Mahi
Description: Biomarkers reduce the attrition rate of late stage clinical trials by assessing efficacy and toxicity at the early stages of clinical development. They can significantly increase productivity, lower clinical trial costs and speed up drug development.

Biopartnering Strategies,Datamonitor report

BI00020-003-Thumbnail Image.png
Date: 2006-12-15
Name(s): Seget, Steven
Description: Out-licensors now have greater leverage over the licensing of their technologies, changing the approach of out-licensing at various stages of the lifecycle and highlighting the need for existing strategies to be adapted to optimize the process.

Biotech Exit Strategies,Datamonitor report

BI00027-021-Thumbnail Image.png
Date: 2009-06-22
Name(s): Seget, Steven
Description: While the biotech venture model has remained relatively unchanged over the past 30 years, the exit strategies employed by companies and venture capitalists have adapted to the market conditions prevailing over time.

Biotech for Wellness,Datamonitor report

BI00010-009-Thumbnail Image.png
Date: 2010-04-29
Name(s): Barton, Cheryl L.
Description: The biotech and nutraceutical industries are targeting similar lifestyle disease growth markets, but from a different standpoint. The need for nnovation and better supported health claims are leading to the convergence of food and biotech.

Biotech M&A Strategies,Datamonitor report

BI00027-015-Thumbnail Image.png
Date: 2008-10-03
Name(s): Marchant, Jeanette
Description: M&A activity in the pharma industry continues to gain momentum as a growing number of companies seek to replenish drug pipelines through biotechnology acquisitions. M&As between biotech companies are also growing in number.

BNC research : the Canadian book market

sfulibr_65-Thumbnail Image.png
Description: The book industry changes at an accelerated pace and keeping up can be straining — but you don't have to do it alone. BookNet Canada publishes timely and actionable research so that your company is in the know and your staff has the know-how.

BookStats, Volume 4, a comprehensive study of the U.S. publishing industry: featuring data for calendar year 2013

sfulibr_250-Thumbnail Image.png
Date: 2014

Building Biotech Technology Transfer Opportunities,Datamonitor report

BI00027-033-Thumbnail Image.png
Date: 2010-02-25
Name(s): Sahoo, Alison
Description: While some drug makers and technology developers have optimized their biotech tech transfer methodologies, many projects have preventable failures due to poor due diligence or deal structuring, management changes, and inappropriate organization.

Building the Responsive Enterprise,Datamonitor report

BI00029-022-Thumbnail Image.png
Date: 2008-11-15
Name(s): Eastwood, Gary
Description: Enterprises are increasingly demanding instant, pervasive access to business intelligence and enterprise content to support their operations. Responding quickly and accurately to information can mean the difference between success and failure.

Business Intelligence in the Pharmaceutical Market,Datamonitor report

BI00027-036-Thumbnail Image.png
Date: 2010-05-17
Name(s): Mahajan, Rashmi
Description: Pharma companies are increasingly turning to BI to improve information integration and mapping across the various business processes in a bid to get better real-time information, increase efficiency and reduce costs as margin pressures bite.

Callous and cruel: use of force against inmates with mental disabilities in US jails and prisons

sfulibr_1313-Thumbnail Image.png
Date: 2015-05

Canadian publishers digest

sfulibr_291-Thumbnail Image.png
Date: 2011
Description: The one-stop buyers' guide for the Canadian book publishing industry.

Canoe kids : v. 2

sfulibr_1401-Thumbnail Image.png
Date: 2016

Canoe kids : v. 3

sfulibr_1402-Thumbnail Image.png
Date: 2017